HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial

Tissue Antigens

Volumn 85, Issue 2, 2015, Pages 117-126

  Baldwin, K M ^a,b   Ehrenberg, P K ^a   Geretz, A ^a,b   Prentice, H A ^b   Nitayaphan, S ^c   Rerks Ngarm, S ^d   Kaewkungwal, J ^e   Pitisuttithum, P ^e   O'Connell, R J ^c   Kim, J H ^a   Thomas, R ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

HIV 1; HLA DPB1; HLA DQB1; HLA DRB1; Human leukocyte antigen; RV144

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA-DPB1 ANTIGEN; HLA-DQB1 ANTIGEN;

ALLELE; AMBIGUITY; ARTICLE; COHORT ANALYSIS; EXON; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; NEXT GENERATION SEQUENCING; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; THAILAND; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS VACCINES; ALLELES; GENE FREQUENCY; GENETIC VARIATION; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV INFECTIONS; HIV-1; HLA-DP BETA-CHAINS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; PLACEBOS; THAILAND; TREATMENT OUTCOME;

EID: 84922503588     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12507     Document Type: Article

References (31)

1. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009: 361: 2209-20.
2. Haynes BF, Gilbert PB, McElrath MJ et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 2012: 366: 1275-86.
3. Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Poland GA. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine 2007: 25: 3090-100.
4. Caillat-Zucman S, Gimenez JJ, Wambergue F et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int 1998: 53: 1626-30.
5. Stephens HA, Brown AE, Chandanayingyong D et al. The presence of the HLA class II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen. Eur J Immunol 1995: 25: 3142-7.
6. Paris R, Bejrachandra S, Thongcharoen P et al. HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX((R)) B/E. Vaccine 2012: 30: 832-6.
7. Romphruk AV, Romphruk A, Kongmaroeng C, Klumkrathok K, Paupairoj C, Leelayuwat C. HLA class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens 2010: 75: 701-11.
8. Romphruk AV, Puapairoj C, Romphruk A, Barasrux S, Urwijitaroon Y, Leelayuwat C. Distributions of HLA-DRB1/DQB1 alleles and haplotypes in the north-eastern Thai population: indicative of a distinct Thai population with Chinese admixtures in the central Thais. Eur J immunogenet 1999: 26: 129-33.
9. Maneemaroj R, Stephens HA, Chandanayingyong D, Longta K, Bejrachandra S. HLA class II allele frequencies in northern Thais (Kamphaeng Phet). J Med Assoc Thai 1997: 80 (Suppl 1): S20-4.
10. Prentice HA, Ehrenberg PK, Baldwin KM et al. HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial. Immunogenetics 2014: 66: 299-310.
11. Ehrenberg PK, Geretz A, Baldwin KM et al. High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging. BMC Genomics 2014: 15: 864.
12. van der Zwan A, Griffith B, Rozemuller E, Williams T, Tilanus MG. Sequence-based typing for HLA-DQB1: strategy for ABI sequencing equipment. In: Hansen JA, ed. Immunobiology of the Human MHC. Seattle, WA: International Histocompatability Working Group Press, 2006.
13. Hosomichi K, Jinam TA, Mitsunaga S, Nakaoka H, Inoue I. Phase-defined complete sequencing of the HLA genes by next-generation sequencing. BMC Genomics 2013: 14: 355.
14. Ganguly T, Chen P, Teetsel R, Zhang LP, Papaioannou E, Cianciarulo J. High-throughput sequencing of high copy number plasmids from bacterial cultures by heat lysis. Biotechniques 2005: 39: 304 306, 308.
15. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995: 12: 921-7.
16. Trachtenberg E, Vinson M, Hayes E et al. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 2007: 70: 455-63.
17. Yang KL, Chen SP, Shyr MH, Lin PY. High-resolution human leukocyte antigen (HLA) haplotypes and linkage disequilibrium of HLA-B and -C and HLA-DRB1 and -DQB1 alleles in a Taiwanese population. Hum Immunol 2009: 70: 269-76.
18. Machulla HK, Batnasan D, Steinborn F et al. Genetic affinities among Mongol ethnic groups and their relationship to Turks. Tissue Antigens 2003: 61: 292-9.
19. Hoa BK, Hang NT, Kashiwase K et al. HLA-A, -B, - C, -DRB1 and -DQB1 alleles and haplotypes in the Kinh population in Vietnam. Tissue Antigens 2008: 71: 127-34.
20. Saito S, Ota S, Yamada E, Inoko H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 2000: 56: 522-9.
21. Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 2005: 65: 437-47.
22. Rani R, Sood A, Goswami R. Molecular basis of predisposition to develop type 1 diabetes mellitus in North Indians. Tissue Antigens 2004: 64: 145-55.
23. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007: 68: 779-88.
24. Lauterbach N, Voorter CE, Stallinga CM, Groeneweg M, Wieten L, Tilanus MG. Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin. Tissue Antigens 2012: 79: 165-73.
25. Chandanayingyong D, Stephens HA, Fan L et al. HLA-DPB1 polymorphism in the Thais of Southeast Asia. Hum Immunol 1994: 40: 20-4.
26. Thomas R, Thio CL, Apps R et al. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol 2012: 86: 6979-85.
27. Price P, Witt C, Allcock R et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999: 167: 257-74.
28. Chandanayingyong D, Stephens HA, Klaythong R et al. HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais. Hum Immunol 1997: 53: 174-82.
29. Wolf PR, Ploegh HL. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol 1995: 11: 267-306.
30. Cammarota G, Scheirle A, Takacs B et al. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature 1992: 356: 799-801.
31. Gragert L, Madbouly A, Freeman J, Maiers M. Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Hum Immunol 2013: 74: 1313-20.